Clinical Study

Insights on Embolic Protection, Repositioning, and Stroke: A Subanalysis of the RESPOND Study

Figure 2

Comparative reduction in stroke risk with cerebral embolic protection. Use of a dual-filter cerebral embolic protection (CEP) device during transcatheter aortic valve replacement was associated with a numerical reduction in acute stroke in RESPOND, which is in concordance with that observed in other clinical analyses. 15Seeger et al., JACC: Cardiovascular Interventions, 10, 2297–2303, 2017. 14Data presented at SENTINEL CPS FDA Advisory Panel, February 23, 2017; accessed at https://www.fda.gov/media/103414/download. 6Seeger et al., European Heart Journal, 40, 1334–1340, 2019. 7Falk et al., European Heart Journal, 38, 3359–3366, 2017.